Perampanel

Chemical formula: C₂₃H₁₅N₃O  Molecular mass: 349.393 g/mol  PubChem compound: 9924495

Therapeutic indications

Perampanel is indicated for:

Partial-onset seizures with or without secondarily generalised seizures

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Perampanel is indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in adult and adolescent patients from 12 years of age with epilepsy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Primary generalised tonic-clonic seizures

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Perampanel is indicated for the adjunctive treatment of primary generalised tonic-clonic seizures in adult and adolescent patients from 12 years of age with idiopathic generalised epilepsy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2020: FYCOMPA Film-coated tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈